References
- Malanoski GJ, Collins L, Wennersten C, Morellering RC, Eliopoulos GM. In vitro activity of biapenem against clini-cal isolates of gram-positive and gram-negative bacteria. Antimicrob Agents Chemother 1993; 37: 2009–2016.
- Sasaki S, Murakami K, Nishitani Y, Kuwahara S. 5-4661, a new carbapenem. I. In vitro antibacterial activity (abstract F33); in Program and Abstracts of the 34th Interscience Conference on Antimicrobial Agents and Chemotherapy, Orlando, Fla. Washington DC: American Society for Microbiology, 1994.
- Miwa H, Sasaki S, Shimada J, Kuwahara. S-4661, a new carbapenem. II. In vivo antibacterial activity (abstract F35); in Program and Abstracts of the 34th Interscience Conference on Antimicrobial Agents and Chemotherapy, Orlando, Fla. Washington DC: American Society for Microbiology, 1994.
- Inoue M, Mitsuhashi S. Antibacterial activity of new car-bapenem S-4661 and stability to beta-lactamase (abstract F112); in Program and Abstracts of the 36th Interscience Conference on Antimicrobial Agents and Chemotherapy, New Orleans, La. Washington DC: American Society for Microbiology, 1996.
- Miwa H, Matsuda H, Shimada J, Kuwahara S. Effect of S-4661, a new carbapenem antibiotic, on endotoxin release from Pseudomonas aeruginosa (abstract F114); in Program and Abstracts of the 36th Interscience Conference on Antimicrobial Agents and Chemotherapy, New Orleans, La. Washington DC: American Society for Microbiology, 1996.
- Kimura Y, Murakami K, Onoue H, Shimada J, Kuwahara S. S-4661, a new carbapenem. III. Pharmacokinetics in laboratory animals (Abstract F37); in Program and Abstracts of the 34th Interscience Conference on Antimicrobial Agents and Chemotherapy, Orlando, Fla. Washington DC: American Society for Microbiology, 1994.
- Japanese Society for Chemotherapy. Method for the determination of minimum inhibitory concentration (MIC) for bacteria by the agar dilution method. Chemotherapy (Tokyo) 1981; 29: 76.
- T suji M, Ishii Y, Ohono A, Miyazaki S, Yamaguchi K. In vitro and in vivo antibacterial activities of S-4661, a new car-bapenem. Antimicrob Agents Chemother 1998; 42: 94–99.
- Mikamo H, Izumi K, Hua YX, Hayasaki Y, Sato Y, Tamaya T. In vitro and in vivo antibacterial activities of a new injectable carbapenem, S-4661, against gynaecological pathogens. J Antimicrob Chemother 2000; 46: 471–474.
- Watanabe A, Takahashi H, Kikuchi T, et al. Comparative in vitro activity of S-4661 parenteral carbapen-em, and other antimicrobial agents against respiratory pathogens. Chemotherapy 2000; 46: 184–187.
- Nakashina M, Kato T, Kimura Y, Sasaki S, Konishi M, Oguma T. S-4661, a new carbapenem: IV. Pharmacokinetics in healthy volunteers (abstract F596); in Program and Abstracts of the 34th Interscience Conference on Antimicrobial Agents and Chemotherapy, Orlando, Fla. Washington DC: American Society for Microbiology, 1994.
- Hon S, Sato J, Kawamura M, Shimada J. S-4661, a new carbapenem, has weak convulsant activity. A comparative study on convulsant activity of carbapenems and cephalosporins (abstract F220); in Program and Abstracts of the 37th Interscience Conference on Antibacterial Agents and Chemotherapy, Toronto, Ont., Canada. Washington DC: American Society for Microbiology, 1997.